The realm of pharmaceutical science is constantly evolving, and at the forefront of this revolution stands innovative peptide synthesis. These minute protein fragments hold immense promise for revolutionizing healthcare. Researchers are utilizing the power of engineered peptides to design novel therapeutics for a broad range of conditions. Rega

Peptide companies in the United States have witnessed unprecedented growth, with the FDA approving a record number of peptide-based therapeutics in recent years. Indeed, these specialized molecules now account for over 5% of all approved drugs, underscoring their growing importance in modern medicine. The complex nature of peptide synthesis necessi